
News|Articles|June 18, 2024
The Nuances of Patient Selection: Why Some Trials Need Eligibility Adjudication
Author(s)WCG
Patient selection can be a nuanced process in clinical trials, particularly those involving therapeutic areas with more complex or subjective inclusion/exclusion criteria. Determining patient eligibility may often depend on factors that require clinical expertise in such areas as disease progression, comorbidities, genetic mutations, and disease severity. Discover the role eligibility adjudication committees play in ensuring trial success.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Trending on Applied Clinical Trials Online
1
Evinova, Bristol Myers Squibb Partner to Apply AI to Global Clinical Development
2
SCOPE Summit 2026: How Payment Practices and Operational Burden Are Changing Site Behavior
3
ACT Brief: Purpose Meets Operational Focus, Acceleration Shifts Upstream, and AI Delivers Near-Term Impact
4
SCOPE Summit 2026: How Sponsors Are Prioritizing AI Adoption Across Clinical Trials
5